21,032 Shares in Waters Corporation $WAT Acquired by Nuance Investments LLC

Nuance Investments LLC bought a new position in shares of Waters Corporation (NYSE:WAT) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund bought 21,032 shares of the medical instruments supplier’s stock, valued at approximately $7,341,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Zions Bancorporation National Association UT bought a new position in shares of Waters during the first quarter valued at $28,000. IFP Advisors Inc increased its holdings in Waters by 118.9% in the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock valued at $30,000 after purchasing an additional 44 shares during the period. Caitong International Asset Management Co. Ltd bought a new position in Waters during the 1st quarter worth $41,000. Creative Financial Designs Inc. ADV lifted its holdings in Waters by 533.3% during the 2nd quarter. Creative Financial Designs Inc. ADV now owns 190 shares of the medical instruments supplier’s stock worth $66,000 after buying an additional 160 shares during the period. Finally, Steph & Co. acquired a new position in Waters during the 2nd quarter worth about $73,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Stock Up 0.2%

Shares of Waters stock opened at $371.97 on Friday. The stock’s 50-day moving average is $323.54 and its 200 day moving average is $326.08. Waters Corporation has a one year low of $275.05 and a one year high of $423.56. The firm has a market cap of $22.15 billion, a price-to-earnings ratio of 33.54, a PEG ratio of 3.19 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22.

Waters (NYSE:WAT) last issued its earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%.The business had revenue of $608.55 million during the quarter. Equities research analysts anticipate that Waters Corporation will post 12.86 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft set a $315.00 price target on Waters and gave the company a “hold” rating in a research note on Tuesday, August 5th. Wall Street Zen lowered Waters from a “buy” rating to a “hold” rating in a research note on Saturday, July 26th. TD Cowen increased their target price on shares of Waters from $345.00 to $390.00 and gave the company a “hold” rating in a research report on Wednesday. Weiss Ratings restated a “hold (c)” rating on shares of Waters in a report on Wednesday, October 8th. Finally, Cowen restated a “hold” rating on shares of Waters in a research report on Wednesday. Two analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, Waters currently has an average rating of “Moderate Buy” and a consensus target price of $381.57.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.